Presbyopia Drops, a Promising Solution - Scorecard - MDSpire

Presbyopia Drops, a Promising Solution

  • By

  • Irene Zhou, BS, MS3

  • Ariana Rose Maleki, BS

  • Dagny Zhu, MD

  • April 1, 2025

  • 9 min

Share

Clinical Scorecard: Presbyopia Drops, a Promising Solution

At a Glance

CategoryDetail
ConditionPresbyopia
Key MechanismsPupil modulation to create a pinhole effect, increasing depth of focus and improving near vision.
Target PopulationPatients over 40 years old, particularly those aged 40 to 50 with early to moderate presbyopia.
Care SettingOphthalmology clinics and practices.

Key Highlights

  • FDA-approved treatments include Pilocarpine hydrochloride ophthalmic solution 1.25% (Vuity) and 0.4% (Qlosi).
  • Presbyopia drops provide a non-invasive alternative to glasses and surgery.
  • Effective patient selection and education are critical for optimal outcomes.
  • Common side effects include headaches and eye irritation.
  • Newer ophthalmic drugs for presbyopia are in trials, with potential for reduced side effects.

Guideline-Based Recommendations

Diagnosis

  • Conduct a thorough eye examination to assess presbyopia severity and patient suitability.

Management

  • Presbyopia drops should be considered for patients not interested in or not candidates for surgical options.

Monitoring & Follow-up

  • Regular follow-up to assess vision improvement and side effects.

Risks

  • Screen for retinal conditions before prescribing due to potential increased risk of retinal complications.

Patient & Prescribing Data

Patients aged 40 and older, particularly those with early to moderate presbyopia.

Vuity is effective for functional near vision when used consistently; Qlosi offers similar benefits with a lower concentration.

Clinical Best Practices

  • Educate patients on the temporary nature of the drops and the importance of adherence to the regimen.
  • Provide clear communication scripts for staff to ensure consistent patient education.
  • Utilize strategies to enhance patient adherence, such as digital reminders and daily usage logs.

References

Original Source(s)

Related Content